Vilanterol Impurity 12 | CAS 452339-71-8 - Request Quote
Vilanterol Impurity 12
| SZ CAT No: | SZ-V031015 |
| CAS No | 452339-71-8 |
| Mol.F. | C17H23NO5 |
| Mol.Wt. | 321.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Vilanterol Impurity 12 is chemically Tert-butyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-oxoethyl)carbamate. Vilanterol Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Vilanterol Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vilanterol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 452339-71-8
Purchase 452339-71-8
Order 452339-71-8
Enquire 452339-71-8
price of 452339-71-8
452339-71-8 Supplier
452339-71-8 Manufacturer
452339-71-8 Exporter
buy high quality Vilanterol Impurity 12
Purchase Vilanterol Impurity 12
Vilanterol Impurity 12 suppliers
Vilanterol Impurity 12 manufacturers
Vilanterol Impurity 12 price
Order Vilanterol Impurity 12
Enquire Vilanterol Impurity 12
Vilanterol Impurity 12 cost
Vilanterol Impurity 12 Supplier
Vilanterol Impurity 12 Distributor
Vilanterol Impurity 12 for Method Validation
Vilanterol Reference Standard
Vilanterol Impurity 12 for ANDA Filing
Vilanterol Impurity 12 for Forced Degradation Studies
Vilanterol Impurity 12 Identification Standards
Vilanterol Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.